Floyd Taub, M.D. - Presentations and Articles on Taurox™ and Chronic Fatigue

Scientific Presentations, Conferences and Public Relations in 2003 & 2004 for Taurox™

Fatigue Reduction and Quality of Life Enhancement Following Therapy with Taurox. (Presentation at Exeter University (UK) December 2006) Floyd E. Taub, M.D., Char Tara Albert, Lesley Crowder, Suzin Mayerson Wright, Ph.D.
11th Annual Meeting of the Society for Orthomolecular Health-Medicine (OHM) in San Francisco, California, February 24-27, 2005, “Fatigue Reduction Due to Changing Cytokine Patterns. Immunostimulation by COBAT (Taurox SB™) in Patients with Lyme Disease”
KFNX News Talk Radio, August 8th, 2004, 8:00 a.m. PST
Floyd Taub, M.D. was interviewed by Dr. Warren Levin, Host of the show, "Third Opinion"
Familynet Television Interview June 17 and 25, 2004
BioInnovations produces a daily television show for the Familynet cable network, which broadcasts to over 30-million viewers mainly in the Midwest and South, hosted by Dr. Richard Becker and his wife Cindy. Allergy Research Group, one of Dovetail’s distributors introduced the Beckers to Dr. Floyd Taub, Dovetail Technology’s Chairman and Chief Medical Officer. Dr. Taub participated in two 30-minute television shows on June 17, 2004 discussing Taurox research. One aired live on Familynet Television that day, the second program aired on June 25, 2004. Familynet is a television service dedicated to health and family matters and provides holistic medical information that is generally not available to its audience other than through Dr. Becker.
Health Sciences Institute (HIS) Newsletter, May 2004 Issue
HIS published an article entitled “What the Goldilocks effect” can do for fatigue and your immune system”, covering Taurox research and products.

Presentations by Dr. Floyd Taub on Taurox and Chronic Fatigue:

Society For Orthomolecular Health-Medicine, 11th Annual Scientific Meeting, About Lyme: Testing, Diagnosis, Therapeutic Protocols, February 27, 2005, San Francisco, California, “Fatigue Reduction Through Changing Cytokine Patterns”.
American Academy of Environmental Medicine 39th Annual Meeting, October 28 - 31, 2004, Hilton Head Island, South Carolina. “Taurox SB™ - the First Available NanoDrug™”
Fourth World Conference on Nutritional Medicine in San Francisco, California American Association for Chronic Fatigue Syndrome, Sixth Biennial. May 28, 2004, “Taurox and NanoDrugs™”
International College of Integrative Medicine International Congress, September 10–September 14, 2003, St. Louis, MO. “Beta Alanine Containing NanoDrugs in the Treatment of Fatigue in Patients with Chronic Fatigue Syndrome Cancer, and HCV.”
First International Conference on Whole Person Healing, March 28–March 30, 2003, Washington, DC. “Immunomodulator Taurox SB™ Reduces Fatigue in Patients with Cancer, HCV and Chronic Fatigue Syndrome.”
International Research and Clinical Conference, January 31–February 2, 2003, Chantilly, VA. “Therapy with the Cytokine Modulator Is Associated with Decreased Fatigue in Patients with Chronic Fatigue.”